Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905722072

SecurityBIO / Bio-Rad Laboratories, Inc.
InstitutionAssetmark, Inc
Latest Disclosed Ownership38,989 shares
Latest Disclosed Value $ 10,868,184
Assetmark, Inc reports 19.00% increase in ownership of BIO / Bio-Rad Laboratories, Inc.

On May 6, 2026 - Assetmark, Inc filed a 13F-HR form disclosing ownership of 38,989 shares of Bio-Rad Laboratories, Inc. (US:BIO) valued at $10,868,184 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 32,765 shares of Bio-Rad Laboratories, Inc.. This represents a change in shares of 19.00% during the quarter. The current value of the position is $11,885,017 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F BIO RAD LABS CL A 090572207 38,989 6,224 19.00 10,868 9.48 0.0222
2026-01-23 2025-12-31 13F BIO RAD LABS CL A 090572207 32,765 3,957 13.74 9,927 22.90 0.0202
2025-11-06 2025-09-30 13F BIO RAD LABS CL A 090572207 28,808 7,633 36.05 8,077 58.09 0.0173
2025-08-04 2025-06-30 13F BIO RAD LABS CL A 090572207 21,175 12,023 131.37 5,110 129.21 0.0121
2025-05-06 2025-03-31 13F BIO RAD LABS CL A 090572207 9,152 1,242 15.70 2,229 -14.20 0.0061
2025-02-06 2024-12-31 13F BIO RAD LABS CL A 090572207 7,910 7,605 2,493.44 2,599 2,447.06 0.0071
2024-11-01 2024-09-30 13F BIO RAD LABS CL A 090572207 305 140 84.85 102 126.67 0.0003
2024-08-13 2024-06-30 13F BIO RAD LABS CL A 090572207 165 -16,794 -99.03 45 -99.23 0.0001
2024-05-07 2024-03-31 13F BIO RAD LABS CL A 090572207 16,959 16 0.09 5,866 7.22 0.0191
2024-02-09 2023-12-31 13F BIO RAD LABS CL A 090572207 16,943 -1,861 -9.90 5,471 -18.84 0.0198
2023-10-27 2023-09-30 13F BIO RAD LABS CL A 090572207 18,804 1,246 7.10 6,740 1.26 0.0270
2023-08-11 2023-06-30 13F BIO RAD LABS INC CL A CL A 090572207 17,558 -937 -5.07 6,657 -24.87 0.0261
2023-05-05 2023-03-31 13F BIO RAD LABS INC CL A CL A 090572207 18,495 1,380 8.06 8,859 23.11 0.0366
2023-02-10 2022-12-31 13F BIO RAD LABS CL A 090572207 17,115 -2,192 -11.35 7,197 -10.65 0.0312
2022-11-01 2022-09-30 13F BIO RAD LABS CL A 090572207 19,307 -113,290 -85.44 8,054 -87.73 0.0377
2022-08-03 2022-06-30 13F BIO RAD LABS INC CL A CL A 090572207 132,597 -11,599 -8.04 65,636 -19.18 0.2942
2022-05-13 2022-03-31 13F BIO RAD LABS INC CL A CL A 090572207 144,196 -1,576 -1.08 81,216 -26.26 0.3399
2022-02-14 2021-12-31 13F BIO RAD LABS INC CL A CL A 090572207 145,772 6,935 5.00 110,141 6.35 0.4525
2021-11-12 2021-09-30 13F BIO RAD LABS INC CL A CL A 090572207 138,837 -7,253 -4.96 103,565 10.03 0.4640
2021-08-16 2021-06-30 13F BIO RAD LABS INC CL ACUSIP NO ISSUER NAME ISSUER CL A 090572207 146,090 6,713 4.82 94,124 18.23 0.4365
2021-05-14 2021-03-31 13F BIO RAD LABS CL A 090572207 139,377 8,842 6.77 79,608 4.62 0.4106
2021-02-10 2020-12-31 13F BIO RAD LABS INC CL A CL A 090572207 130,535 463 0.36 76,094 13.49 0.4240
2020-11-13 2020-09-30 13F BIO RAD LABS INC CL A CL A 090572207 130,072 50,096 62.64 67,047 93.51 0.4326
2020-08-11 2020-06-30 13F BIO RAD LABS INC CL A CL A 090572207 79,976 63,478 384.76 34,647 499.01 0.2479
2020-05-12 2020-03-31 13F BIO RAD LABS INC CL A CL A 090572207 16,498 16,498 5,784 0.0490
2019-05-14 2019-03-31 13F BIO RAD LABS INC CL A CL A 090572207 0 -5 -100.00 0 -100.00
2019-02-13 2018-12-31 13F BIO RAD LABS INC CL A CL A 090572207 5 -19 -79.17 1 -87.50 0.0000
2018-11-13 2018-09-30 13F BIO RAD LABS INC CL A CL A 090572207 24 24 8 0.0001
2015-11-10 2015-09-30 13F BIO RAD LABS INC CL A COM 090572207 0 -4,754 -100.00 0 -100.00
2015-08-13 2015-06-30 13F BIO RAD LABS INC CL A COM 090572207 4,754 4,754 716 0.0149
2015-02-03 2014-12-31 13F BIO RAD LABS INC CL A CL A 090572207 0 -10,546 -100.00 0 -100.00
2014-11-10 2014-09-30 13F BIO RAD LABS INC CL A CL A 090572207 10,546 10,546 -33.92 1,196 -36.25 0.0276
2014-02-11 2013-12-31 13F BIO RAD LABS INC CL A CL A 090572207 0 -15,959 -100.00 0 -100.00
2014-02-11 2013-09-30 13F/A-1 BIO RAD LABS INC CL A CL A 090572207 15,959 15,959 1,876 0.0474
2013-11-14 2013-09-30 13F BIO RAD LABS INC CL A CL A 090572207 15,959 1,876 0.0474
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.